Peter A. Thompson's Net Worth

$668 Million

Who is Peter A. Thompson?

Peter A. Thompson has an estimated net worth of $668 Million. This is based on reported shares across multiple companies, which include Trubion Pharmaceuticals, Inc, PMV Pharmaceuticals, Inc., Mirati Therapeutics, Inc., ALPINE IMMUNE SCIENCES, INC., Janux Therapeutics, Inc., Edgewise Therapeutics, Inc., ProNAi Therapeutics Inc, Adaptimmune Therapeutics PLC, Prevail Therapeutics Inc., Synthorx, Inc., ARS Pharmaceuticals, Inc., Corvus Pharmaceuticals, Inc., Decibel Therapeutics, Inc., RESPONSE BIOMEDICAL CORP, Anthera Pharmaceuticals Inc, and Principia Biopharma Inc..

SEC CIK

Peter A. Thompson's CIK is 0001357522

Past Insider Trading and Trends

2016 was Peter A. Thompson's most active year for acquiring shares with 26 total transactions. Peter A. Thompson's most active month to acquire stocks was the month of May. 2021 was Peter A. Thompson's most active year for disposing of shares, totalling 20 transactions. Peter A. Thompson's most active month to dispose stocks was the month of February. 2020 saw Peter A. Thompson paying a total of $42,100,017.00 for 15,359,492 shares, this is the most they've acquired in one year. In 2020 Peter A. Thompson cashed out on 38,110,700 shares for a total of $372,624,766.00, their largest year based on trade value.